Practical guidance for the management of inflammatory bowel disease in patients with cancer. Which treatment?

Clinicians involved in the treatment of inflammatory bowel disease (IBD) increasingly come across patients with current or previous history of malignancies. With increasing and earlier use of immunosuppression and biologics in IBD patients, the question arises whether these treatments further increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebastian, Shaji, Neilaj, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322094/
https://www.ncbi.nlm.nih.gov/pubmed/30643542
http://dx.doi.org/10.1177/1756284818817293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322094/
https://www.ncbi.nlm.nih.gov/pubmed/30643542
http://dx.doi.org/10.1177/1756284818817293

Ejemplares similares